PDA TR 54-2

Technical Report No. 54-2 (TR 54-2) Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operation: Annex 1: Case Study Examples for Quality Risk Management in Packaging and Labeling

Parenteral Drug Association , 06/01/2013

Publisher: PDA

File Format: PDF

$162.00$325.00


The first Annex to Technical Report No. 54: Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations provides specific case studies on how to apply quality risk management (QRM) to pharmaceutical manufacturing, specifically packaging and labeling operations. This report is intended to align with ICH Q9 and is one in a series of similar documents that provide additional examples of how to apply risk management tools across the product supply chain. Technical Report No. 54-2 was drafted by an all-volunteer team of experts representing companies like Merck, Amgen and Genentech.

More PDA Standards PDF

PCI CB-02-16

PCI CB-02-16

$60.00 $121.00

NZS 1170.5:2004A1

NZS 1170.5:2004A1

$86.00 $172.98

NZS 1170.5:2004 SUPP1A1

NZS 1170.5:2004 SUPP1A1

$139.00 $278.27

NZS 4246:2016

NZS 4246:2016

$111.00 $222.09